Applied Therapeutics Inc (NASDAQ:APLT)’s traded shares stood at 1.42 million during the last session, with the company’s beta value hitting 1.81. At the close of trading, the stock’s price was $6.80, to imply a decrease of -0.73% or -$0.05 in intraday trading. The APLT share’s 52-week high remains $9.39, putting it -38.09% down since that peak but still an impressive 88.82% since price per share fell to its 52-week low of $0.76. The company has a valuation of $720.05M, with an average of 0.97 million shares in intraday trading volume over the past 10 days and average of 2.19 million shares over the past 3 months.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
After registering a -0.73% downside in the last session, Applied Therapeutics Inc (APLT) has traded red over the past five days. The stock hit a weekly high of 7.39, dropping -0.73% in its intraday price action. The 5-day price performance for the stock is -0.37%, and -8.11% over 30 days. With these gigs, the year-to-date price performance is 102.99%. Short interest in Applied Therapeutics Inc (NASDAQ:APLT) saw shorts transact 3.79 million shares and set a 1.05 days time to cover.
Applied Therapeutics Inc (APLT) estimates and forecasts
Looking at statistics comparing Applied Therapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Applied Therapeutics Inc (APLT) shares are 157.58% up over the last 6 months, with its year-to-date growth rate higher than industry average at 62.68% against 13.00%. Revenue is forecast to grow 22.20% this quarter before jumping 54.10% for the next one. The rating firms project that company’s revenue will shrink -22.60% compared to the previous financial year.
Revenue forecast for the current quarter as set by 3 analysts is $3.33 million.
APLT Dividends
Applied Therapeutics Inc has its next earnings report out between May 09 and May 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Applied Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders
Applied Therapeutics Inc insiders hold 6.91% of total outstanding shares, with institutional holders owning 69.56% of the shares at 74.72% float percentage. In total, 69.56% institutions holds shares in the company, led by Franklin Resources, Inc.. As of Jun 29, 2023, the company held over 7.95 million shares (or 12.59% of shares), all amounting to roughly $10.17 million.
The next major institution holding the largest number of shares is VR Adviser, LLC with 5.66 million shares, or about 8.96% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $7.24 million.
We also have Franklin Strategic Series-Franklin Biotechnology Discove and Fidelity Select Portfolios – Biotechnology as the top two Mutual Funds with the largest holdings of the Applied Therapeutics Inc (APLT) shares. Going by data provided on Jul 30, 2023, Franklin Strategic Series-Franklin Biotechnology Discove holds roughly 3.4 million shares. This is just over 5.38% of the total shares, with a market valuation of $6.05 million. Data from the same date shows that the other fund manager holds a little less at 2.64 million, or 4.18% of the shares, all valued at about 3.51 million.
